Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01FBP
|
|||
| Former ID |
DNCL001984
|
|||
| Drug Name |
Vanutide cridificar
|
|||
| Synonyms |
ACC-001
Click to Show/Hide
|
|||
| Indication | Alzheimer disease [ICD-11: 8A20; ICD-10: G30, G30.9; ICD-9: 331] | Phase 2 | [1] | |
| Company |
Janssen Alzheimer Immunotherapy; Pfizer
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01284387) Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Mild to Moderate Alzheimer's Disease. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.